This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
How can we reduce the burden of cancer?
Implementing the research agenda of the National Cancer Institute’s Cancer Epidemiology and Genetics Program
Challenge
Scientists at the National Cancer Institute’s (NCI’s) Division of Cancer Epidemiology and Genetics (DCEG) work to understand genetic and environmental determinants of cancer. They study many different types of cancer, employ a wide range of study designs, include diverse populations, and collect a broad array of epidemiologic and clinical data, as well as biological and environmental samples.
These complex, multidisciplinary studies need considerable infrastructure and resources for successful conduct, such as clinical staff and experts in the collection and handling of biological and environmental samples. For many of DCEG’s longitudinal cohort studies, expertise is needed in long-term followup methods and linking cohorts to disease and death registries. Most studies require acquiring, editing, merging, and harmonizing data from multiple sources sometimes collected over the course of many years; maintaining the data in secure databases; and preparing analytic datasets.
Solution
For the past 40 years, Westat has provided research support services to DCEG investigators. We currently hold 6 contracts supporting 50 to 70 active studies.
Our large and highly skilled workforce has advanced, specialized capabilities in
- Multimode data collection from individuals and healthcare delivery sources
- Clinical data collection
- Genetic counseling
- Biological and environmental sample collection and management
- Exposure assessment
- Geospatial analysis
- Data linkages
- Management of complex biomedical data from multiple sources
We successfully manage multiple studies conducted concurrently and respond quickly to address newly emerging scientific questions.
Results
Westat is proud to support research that has made major contributions to our understanding of the causes, progression, prevention, and detection of cancer. Examples include studies that have identified genetic mutations associated with cancer in high-risk individuals, studies to understand the associations of infections with cancer and progression from precancerous lesions, and studies to understand the interrelationships between environmental and genetic factors in cancer.
Focus Areas
Clinical Trials Coordinating Centers Multisite Epidemiology Studies Public HealthCapabilities
Data Collection Data Collection Modes Data Harmonization and Data LinkageSenior Expert Contact
Jeanne Rosenthal
Vice President
-
Perspective
Diverse Journeys: Westat Women in LeadershipMarch 2024
In celebration of Women’s History Month, we’re shining a spotlight on the remarkable women leaders at Westat. Their diverse backgrounds, experiences, and insights have helped…
-
Perspective
Spotlight on Maternal Mental HealthMarch 2024
Mental health conditions are the most common complications during pregnancy and the postpartum period. The Centers for Disease Control and Prevention (CDC) identifies mental health…
-
Perspective
Access to Birthing-Friendly Facilities for Maternal CareFebruary 2024
Preventable maternal mortality in the U.S. has grown considerably and spurred the federal government into action, most noticeably with the development of the White House…